Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1997 Jul;65(7):2786–2791. doi: 10.1128/iai.65.7.2786-2791.1997

Rickettsia rickettsii infection of cultured human endothelial cells induces NF-kappaB activation.

L A Sporn 1, S K Sahni 1, N B Lerner 1, V J Marder 1, D J Silverman 1, L C Turpin 1, A L Schwab 1
PMCID: PMC175393  PMID: 9199451

Abstract

Rickettsia rickettsii, the etiologic agent of Rocky Mountain spotted fever, is an obligate intracellular bacterial organism that infects primarily the vascular endothelial cells (EC). A component of the EC response to infection is transcriptional activation, which may contribute to the thrombotic and inflammatory consequences of disease. In this study, we explore R. rickettsii-induced activation of the nuclear factor-kappaB/Rel (NF-kappaB) family of transcription factors involved in early transcriptional responses to injurious stimuli. Two NF-kappaB species were activated by infection and reacted with a double-stranded oligonucleotide probe corresponding to the kappaB binding domain of the murine kappa light-chain gene enhancer. Gel supershift analysis demonstrated the reactivity of these complexes with antibodies against p65 and p50, and the induced species were tentatively identified as p50-p50 homodimers and p50-p65 heterodimers. Semiquantitative reverse transcription-PCR analysis revealed dramatic increases in the steady-state levels of mRNA coding for the inhibitory subunit of NF-kappaB (IkappaB alpha), transcription of which is enhanced by the binding of NF-kappaB within the IkappaB alpha promoter region. NF-kappaB activation was first detected 1.5 h following infection and was biphasic, with an early peak of activation at approximately 3 h, a return to baseline levels at 14 h, and even higher levels of activation at 24 h. It is likely that NF-kappaB activation requires cellular uptake of R. rickettsii, since treatment of EC with cytochalasin B during infection to block entry inhibited activation by only 70% at 3 h. R. rickettsii-induced activation of NF-kappaB may be an important controlling factor in the transcriptional responses of EC to infection with this obligate intracellular organism.

Full Text

The Full Text of this article is available as a PDF (1.1 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Collins T. Endothelial nuclear factor-kappa B and the initiation of the atherosclerotic lesion. Lab Invest. 1993 May;68(5):499–508. [PubMed] [Google Scholar]
  2. Drancourt M., Alessi M. C., Levy P. Y., Juhan-Vague I., Raoult D. Secretion of tissue-type plasminogen activator and plasminogen activator inhibitor by Rickettsia conorii- and Rickettsia rickettsii-infected cultured endothelial cells. Infect Immun. 1990 Aug;58(8):2459–2463. doi: 10.1128/iai.58.8.2459-2463.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Dyer R. B., Collaco C. R., Niesel D. W., Herzog N. K. Shigella flexneri invasion of HeLa cells induces NF-kappa B DNA-binding activity. Infect Immun. 1993 Oct;61(10):4427–4433. doi: 10.1128/iai.61.10.4427-4433.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Gimbrone M. A., Jr, Cotran R. S., Folkman J. Human vascular endothelial cells in culture. Growth and DNA synthesis. J Cell Biol. 1974 Mar;60(3):673–684. doi: 10.1083/jcb.60.3.673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Grilli M., Chiu J. J., Lenardo M. J. NF-kappa B and Rel: participants in a multiform transcriptional regulatory system. Int Rev Cytol. 1993;143:1–62. doi: 10.1016/s0074-7696(08)61873-2. [DOI] [PubMed] [Google Scholar]
  6. Hansen S. K., Nerlov C., Zabel U., Verde P., Johnsen M., Baeuerle P. A., Blasi F. A novel complex between the p65 subunit of NF-kappa B and c-Rel binds to a DNA element involved in the phorbol ester induction of the human urokinase gene. EMBO J. 1992 Jan;11(1):205–213. doi: 10.1002/j.1460-2075.1992.tb05043.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hauf N., Goebel W., Serfling E., Kuhn M. Listeria monocytogenes infection enhances transcription factor NF-kappa B in P388D1 macrophage-like cells. Infect Immun. 1994 Jul;62(7):2740–2747. doi: 10.1128/iai.62.7.2740-2747.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hla T., Maciag T. Cyclooxygenase gene expression is down-regulated by heparin-binding (acidic fibroblast) growth factor-1 in human endothelial cells. J Biol Chem. 1991 Dec 15;266(35):24059–24063. [PubMed] [Google Scholar]
  9. Ivanov V., Stein B., Baumann I., Dobbelaere D. A., Herrlich P., Williams R. O. Infection with the intracellular protozoan parasite Theileria parva induces constitutively high levels of NF-kappa B in bovine T lymphocytes. Mol Cell Biol. 1989 Nov;9(11):4677–4686. doi: 10.1128/mcb.9.11.4677. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kaplanski G., Teysseire N., Farnarier C., Kaplanski S., Lissitzky J. C., Durand J. M., Soubeyrand J., Dinarello C. A., Bongrand P. IL-6 and IL-8 production from cultured human endothelial cells stimulated by infection with Rickettsia conorii via a cell-associated IL-1 alpha-dependent pathway. J Clin Invest. 1995 Dec;96(6):2839–2844. doi: 10.1172/JCI118354. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kunsch C., Rosen C. A. NF-kappa B subunit-specific regulation of the interleukin-8 promoter. Mol Cell Biol. 1993 Oct;13(10):6137–6146. doi: 10.1128/mcb.13.10.6137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Le Bail O., Schmidt-Ullrich R., Israël A. Promoter analysis of the gene encoding the I kappa B-alpha/MAD3 inhibitor of NF-kappa B: positive regulation by members of the rel/NF-kappa B family. EMBO J. 1993 Dec 15;12(13):5043–5049. doi: 10.1002/j.1460-2075.1993.tb06197.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Mackman N., Brand K., Edgington T. S. Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kappa B binding sites. J Exp Med. 1991 Dec 1;174(6):1517–1526. doi: 10.1084/jem.174.6.1517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Nielsch U., Zimmer S. G., Babiss L. E. Changes in NF-kappa B and ISGF3 DNA binding activities are responsible for differences in MHC and beta-IFN gene expression in Ad5- versus Ad12-transformed cells. EMBO J. 1991 Dec;10(13):4169–4175. doi: 10.1002/j.1460-2075.1991.tb04995.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Orthner C. L., Rodgers G. M., Fitzgerald L. A. Pyrrolidine dithiocarbamate abrogates tissue factor (TF) expression by endothelial cells: evidence implicating nuclear factor-kappa B in TF induction by diverse agonists. Blood. 1995 Jul 15;86(2):436–443. [PubMed] [Google Scholar]
  16. Palombella V. J., Rando O. J., Goldberg A. L., Maniatis T. The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B. Cell. 1994 Sep 9;78(5):773–785. doi: 10.1016/s0092-8674(94)90482-0. [DOI] [PubMed] [Google Scholar]
  17. Parry G. C., Mackman N. A set of inducible genes expressed by activated human monocytic and endothelial cells contain kappa B-like sites that specifically bind c-Rel-p65 heterodimers. J Biol Chem. 1994 Aug 19;269(33):20823–20825. [PubMed] [Google Scholar]
  18. Parry G. C., Mackman N. Transcriptional regulation of tissue factor expression in human endothelial cells. Arterioscler Thromb Vasc Biol. 1995 May;15(5):612–621. doi: 10.1161/01.atv.15.5.612. [DOI] [PubMed] [Google Scholar]
  19. Read M. A., Cordle S. R., Veach R. A., Carlisle C. D., Hawiger J. Cell-free pool of CD14 mediates activation of transcription factor NF-kappa B by lipopolysaccharide in human endothelial cells. Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):9887–9891. doi: 10.1073/pnas.90.21.9887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Read M. A., Whitley M. Z., Williams A. J., Collins T. NF-kappa B and I kappa B alpha: an inducible regulatory system in endothelial activation. J Exp Med. 1994 Feb 1;179(2):503–512. doi: 10.1084/jem.179.2.503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Rivière Y., Blank V., Kourilsky P., Israël A. Processing of the precursor of NF-kappa B by the HIV-1 protease during acute infection. Nature. 1991 Apr 18;350(6319):625–626. doi: 10.1038/350625a0. [DOI] [PubMed] [Google Scholar]
  22. Ruben S., Poteat H., Tan T. H., Kawakami K., Roeder R., Haseltine W., Rosen C. A. Cellular transcription factors and regulation of IL-2 receptor gene expression by HTLV-I tax gene product. Science. 1988 Jul 1;241(4861):89–92. doi: 10.1126/science.2838905. [DOI] [PubMed] [Google Scholar]
  23. Sambucetti L. C., Cherrington J. M., Wilkinson G. W., Mocarski E. S. NF-kappa B activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation. EMBO J. 1989 Dec 20;8(13):4251–4258. doi: 10.1002/j.1460-2075.1989.tb08610.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Schwan W. R., Kügler S., Schüller S., Kopecko D. J., Goebel W. Detection and characterization by differential PCR of host eukaryotic cell genes differentially transcribed following uptake of intracellular bacteria. Infect Immun. 1996 Jan;64(1):91–99. doi: 10.1128/iai.64.1.91-99.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Sen R., Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell. 1986 Aug 29;46(5):705–716. doi: 10.1016/0092-8674(86)90346-6. [DOI] [PubMed] [Google Scholar]
  26. Shi R. J., Simpson-Haidaris P. J., Marder V. J., Silverman D. J., Sporn L. A. Increased expression of plasminogen activator inhibitor-1 in R. rickettsii-infected endothelial cells. Thromb Haemost. 1996 Apr;75(4):600–606. [PubMed] [Google Scholar]
  27. Shimizu H., Mitomo K., Watanabe T., Okamoto S., Yamamoto K. Involvement of a NF-kappa B-like transcription factor in the activation of the interleukin-6 gene by inflammatory lymphokines. Mol Cell Biol. 1990 Feb;10(2):561–568. doi: 10.1128/mcb.10.2.561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Silverman D. J. Adherence of platelets to human endothelial cells infected by Rickettsia rickettsii. J Infect Dis. 1986 Apr;153(4):694–700. doi: 10.1093/infdis/153.4.694. [DOI] [PubMed] [Google Scholar]
  29. Sporn L. A., Haidaris P. J., Shi R. J., Nemerson Y., Silverman D. J., Marder V. J. Rickettsia rickettsii infection of cultured human endothelial cells induces tissue factor expression. Blood. 1994 Mar 15;83(6):1527–1534. [PubMed] [Google Scholar]
  30. Sporn L. A., Lawrence S. O., Silverman D. J., Marder V. J. E-selectin-dependent neutrophil adhesion to Rickettsia rickettsii-infected endothelial cells. Blood. 1993 May 1;81(9):2406–2412. [PubMed] [Google Scholar]
  31. Sporn L. A., Marder V. J. Interleukin-1 alpha production during Rickettsia rickettsii infection of cultured endothelial cells: potential role in autocrine cell stimulation. Infect Immun. 1996 May;64(5):1609–1613. doi: 10.1128/iai.64.5.1609-1613.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Sun S. C., Ganchi P. A., Ballard D. W., Greene W. C. NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway. Science. 1993 Mar 26;259(5103):1912–1915. doi: 10.1126/science.8096091. [DOI] [PubMed] [Google Scholar]
  33. Teysseire N., Arnoux D., George F., Sampol J., Raoult D. von Willebrand factor release and thrombomodulin and tissue factor expression in Rickettsia conorii-infected endothelial cells. Infect Immun. 1992 Oct;60(10):4388–4393. doi: 10.1128/iai.60.10.4388-4393.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Wagner D. D., Olmsted J. B., Marder V. J. Immunolocalization of von Willebrand protein in Weibel-Palade bodies of human endothelial cells. J Cell Biol. 1982 Oct;95(1):355–360. doi: 10.1083/jcb.95.1.355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Walker T. S. Rickettsial interactions with human endothelial cells in vitro: adherence and entry. Infect Immun. 1984 May;44(2):205–210. doi: 10.1128/iai.44.2.205-210.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Walker T. S., Winkler H. H. Penetration of cultured mouse fibroblasts (L cells) by Rickettsia prowazeki. Infect Immun. 1978 Oct;22(1):200–208. doi: 10.1128/iai.22.1.200-208.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Whelan J., Ghersa P., Hooft van Huijsduijnen R., Gray J., Chandra G., Talabot F., DeLamarter J. F. An NF kappa B-like factor is essential but not sufficient for cytokine induction of endothelial leukocyte adhesion molecule 1 (ELAM-1) gene transcription. Nucleic Acids Res. 1991 May 25;19(10):2645–2653. doi: 10.1093/nar/19.10.2645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Yurochko A. D., Kowalik T. F., Huong S. M., Huang E. S. Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters. J Virol. 1995 Sep;69(9):5391–5400. doi: 10.1128/jvi.69.9.5391-5400.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES